Concepedia

Publication | Closed Access

Isoliquiritigenin attenuates the invasive capacity of breast cancer cells via up-regulating the tumor suppressor RECK

13

Citations

32

References

2016

Year

Abstract

Isoliquiritigenin attenuated the invasion <italic>via</italic> reducing miR-21 expression, accompanied by induction of RECK and reduction of enzyme activity of MMP9 in breast cancer cells. Our study added novel understandings on the anti-tumor effects of ISL.

References

YearCitations

Page 1